Related Experiment Videos
Hallucinogen binding to dopamine/neuroleptic receptors
The Journal of Pharmacy and Pharmacology
|August 1, 1977
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Demyelinating Charcot-Marie-Tooth neuropathy associated with FBLN5 mutations.
European journal of neurology·2020
Novel SBF2 mutations and clinical spectrum of Charcot-Marie-Tooth neuropathy type 4B2.
Clinical genetics·2018
Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose.
Translational psychiatry·2016
The context-dependent duality of MEG3: a pivotal regulator and promising target in inflammation-associated diseases.
The Journal of pharmacy and pharmacology·2026
Tetrandrine nanocrystals for rheumatoid arthritis: enhanced therapeutic efficacy associated with reduced JAK1 and STAT3 expression.
The Journal of pharmacy and pharmacology·2026
Insulin resistance and asthma: from pathogenic pathways to therapeutic opportunities.
The Journal of pharmacy and pharmacology·2026
Amorphous particles enhance oral exposure-a case study of a poorly soluble compound in preclinical, toxicology and early clinical studies.
The Journal of pharmacy and pharmacology·2026
Neuroprotective euglobals from Eucalyptus tereticornis Smith. leaves: quantification, network pharmacology-guided in silico analysis, and experimental validation.
The Journal of pharmacy and pharmacology·2026
A review of natural plant polysaccharides: the relationship between extraction methods, physicochemical properties, structures, and biological activity.
The Journal of pharmacy and pharmacology·2026
Reorganization of Innate Immune Cell Lipid Profiles by Bioinspired Meroterpenoids to Limit Inflammation.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
A proposed evaluation of new approach methodologies for dermal toxicity assessment of botanicals.
Pharmaceutical biology·2026